|
|
||||||||||||||
|
|
|||||||||||||||
REVIEW |
St Christophers Hospice, London, UK
Correspondence to:
Correspondence to:
Dr Emma J Hall
St Christophers Hospice, 5159 Lawrie Park Road, Sydenham, London SE26 6DZ, UK; emmahall{at}doctors.org.uk
This series of two articles explores the challenge of managing pain in patients with advanced malignant and non-malignant disease. Pain is a common symptom in advanced disease. Despite guidance from organisations such as the World Health Organisation, cancer pain is often inadequately managed. Managing pain in non-malignant conditions, such as end stage cardiac failure, presents an even greater challenge to healthcare professionals. This first article discusses epidemiology, definitions, pathophysiology, assessment, non-pharmacological approaches, the analgesic "ladder", and opioids. The second article will examine the use of non-opioids, anaesthetic techniques, and analgesia in dying patients as well as discussing future directions.
Keywords: malignant; non-malignant; pain; opioids; analgesia; adjuvants; non-opioids; non-pharmacological
Abbreviations: EAPC, European Association of Palliative Care; NMDA, N-methyl-D aspartate; OTFC, oral transmucosal fentanyl citrate; SIGN, Scottish Intercollegiate Guidelines Network; TENS, transcutaneous nerve stimulation; WHO, World Health Organisation
This article has been cited by other articles:
![]() |
E J Hall and N P Sykes Analgesia for patients with advanced disease: 2 Postgrad. Med. J., April 1, 2004; 80(942): 190 - 195. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |